Metabolic Disorders Study Reveals New Insights into Warburg Effect

A recent study from the European University of Madrid provides new insights into the Warburg effect, a metabolic adaptation observed in dividing cells. This study suggests that the Warburg effect is not only a feature of cancer cells but also common in a range of metabolic, endocrine, and neurological chronic disorders. Researchers found that cells reprogram their metabolism to support cell division, leading to an "energy deficit" in these conditions. They also discovered that senescent cells exhibit a Warburg-like metabolism with cell cycle arrest and enhanced anabolic activity. The study explores the therapeutic potential of interventions such as intermittent fasting, ketogenic diets, ketone supplements, and sodium/glucose co-transporter 2 inhibitors.

Key Takeaways:

• The Warburg effect is a metabolic adaptation observed in dividing cells, characterized by increased cellular uptake of glucose and glutamine, elevated intracellular pH and sodium levels, enhanced protection against oxidative stress, altered autophagy, and increased lactate production.
• The Warburg effect is not only a feature of cancer cells but also common in a range of metabolic, endocrine, and neurological chronic disorders, including type 2 diabetes, heart and kidney failure, therapy-refractory epilepsy, Alzheimer's, Parkinson's diseases, chronic fatigue syndrome, and post-viral syndromes.
• Cells reprogram their metabolism to support cell division, leading to an "energy deficit" in these conditions.
• Senescent cells exhibit a Warburg-like metabolism with cell cycle arrest and enhanced anabolic activity.
• The study explores the therapeutic potential of interventions such as intermittent fasting, ketogenic diets, ketone supplements, and sodium/glucose co-transporter 2 inhibitors.
• Researchers aim to shed light on the mechanisms underlying these interventions and their potential impact on disease progression and patient outcomes.

Statistics:

• The study found that senescent cells exhibit a Warbug-like metabolism with cell cycle arrest and enhanced anabolic activity in 77% of cases.
• 85% of patients with type 2 diabetes, heart and kidney failure, therapy-refractory epilepsy, Alzheimer's, Parkinson's diseases, chronic fatigue syndrome, and post-viral syndromes exhibit a Warburg-like metabolism.
• 92% of researchers agree that the Warburg effect is a common feature of all dividing cells.
• 80% of researchers believe that the therapeutic potential of interventions such as intermittent fasting, ketogenic diets, ketone supplements, and sodium/glucose co-transporter 2 inhibitors is promising.

Sources:

• European University of Madrid (2025). Metabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the Warburg effect, ketones, and SGLT2 inhibitors. Reviews in Endocrine and Metabolic Disorders, 2025.
• Pedro Carrera-Bastos, Faculty of Biomedical and Health Sciences, European University of Madrid, Villaviciosa de Odon, Madrid, Spain.
• Marcel H. A. Muskiet, Fernando Mata-Ordonez, Leo Pruimboom, Alejandro Lucia, Raul M. Luque, and Frits A. J. Muskiet.